The FS study needs to be presented to shareholders so we can make an informed choice and valuation. Two months left for FID, it's later in the piece than I was expecting based on comments from Tim in interviews up to a month ago.
- Forums
- ASX - By Stock
- General Chat / Discussion
IXR
ionic rare earths limited
Add to My Watchlist
10.0%
!
1.1¢

The FS study needs to be presented to shareholders so we can...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
0.001(10.0%) |
Mkt cap ! $55.30M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $63.65K | 5.824M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
47 | 32521653 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 2373294 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
47 | 32521653 | 0.010 |
23 | 17631996 | 0.009 |
23 | 19836661 | 0.008 |
42 | 19442836 | 0.007 |
29 | 11186987 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 2373294 | 6 |
0.012 | 6824388 | 17 |
0.013 | 7103941 | 10 |
0.014 | 5224064 | 12 |
0.015 | 2392525 | 6 |
Last trade - 13.11pm 26/06/2025 (20 minute delay) ? |
Featured News
IXR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online